A Three-Part Intervention To Change the Use of Hormone Replacement Therapy in Response to New Evidence

  1. Christianne L. Roumie, MD;
  2. Eric L. Grogan, MD;
  3. William Falbe, PharmD;
  4. Joseph Awad, MD;
  5. Theodore Speroff, PhD;
  6. Robert S. Dittus, MD, MPH; and
  7. Tom A. Elasy, MD, MPH
  1. From Veterans Administration Tennessee Valley Healthcare System and Vanderbilt University, Nashville, Tennessee.
    1. Figure 1. ACY = Alvin C. York Medical Center; CBOC = community-based outpatient center.
      View larger version:
      Figure 1. ACY = Alvin C. York Medical Center; CBOC = community-based outpatient center. Study timeline.
    2. Figure 2. Hazard ratio, 4.9 (95% CI, 1.8 to 13.1). ACY = Alvin C. York Medical Center; CBOC = community-based outpatient center.
      View larger version:
      Figure 2. Hazard ratio, 4.9 (95% CI, 1.8 to 13.1). ACY = Alvin C. York Medical Center; CBOC = community-based outpatient center. Discontinuation of hormone replacement therapy (HRT).
    3. Appendix Figure 1.
      View larger version:
      Appendix Figure 1. Provider education e-mail.
    4. Appendix Figure 2.
      View larger version:
      Appendix Figure 2. Patient education letter.
    5. Appendix Figure 3.
      View larger version:
      Appendix Figure 3. Pharmacy alert.

    Summary for Patients

    • Summaries for Patients:Reducing the Prescription of Hormone Replacement Therapy after the Release of Study Results Ann Intern Med July 20, 2004 141:I-47
    « Previous | Next Article »Table of Contents

    This Article

    1. Ann Intern Med July 20, 2004 vol. 141 no. 2 118-125
    1. AbstractFREE
    2. » Figures
    3. Full Text
    4. Full Text (PDF)
      1. Summary for Patients

    Rapid Responses

    1. Submit a response
    2. No responses published

    Current Issue

    1. November 3, 2009, 151 (9)
    1. Alert me to current issues